UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more

follow us on twitter

Latest Announcements


Tim Barnes, Director of UCL Advances

UCL Advances Director Timothy Barnes recognised for contribution to supporting entrepreneurs in Maserati 100 list

Director of UCL Advances Timothy Barnes has been included on the Maserati 100 list in recognition of his contribution to supporting the next generation of budding entrepreneurs and growing small businesses. The list was prepared by the independent Centre for Entrepreneurs in partnership with the Sunday Times. More...


UCL start-up BaseStone secures contract with the Costain Skanska Joint Venture following successful trials

BaseStone – a London-based software firm started by UCL MSc Technology Entrepreneurship graduate Alex Siljanovski – has secured a long term contract with construction Costain Skanska Joint Venture (CSJV) following trials on their Paddington site that revealed large cost savings through the use of its technology. More...

Ipsen Enters into Option Agreement to Acquire Canbex Therapeutics

Ipsen (Euronext: IPN; ADR: IPSEY) and Canbex Therapeutics Ltd (Canbex) today announced that Canbex has granted Ipsen an option giving Ipsen the exclusive right to purchase 100% of Canbex shares upon completion of the Phase IIa study of Canbex’s lead candidate for the treatment of spasticity in people with multiple sclerosis (MS), known as VSN16R. Canbex is a spin-off of University College London (UCL) that raised a Series A financing of GBP 2.3 million in 2013 from MS Ventures (the corporate venture arm of Merck Serono, Merck KGaA), the Wellcome Trust and UCL Business Plc (UCLB). More...


UCL Institute of Biomedical Engineering

Medtec UK

This year the UCL Institute of Biomedical Engineering will be part of the Medtec UK exhibition, which takes place on 3rd and 4th March at the ExCel Centre.


Utilising Digital and Social Media

This one-day workshop will ensure that your business has the insight and knowledge to successfully utilize the various digital and social media tools available. More...

NIMAX Theatres

Entrepreneurship Guest Lecture Series - Nica Burns, NIMAX Theatres

What’s life like as an entrepreneur? Find out about the highs and lows of the entrepreneurial journey from our inspirational guest speakers, all leading figures in entrepreneurship and investment. More...


London is a scientific powerhouse – and it’s about more than Nobel Prizes

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
THE AWARD of the Nobel Prize in Physiology or Medicine this week to London-based professor John O’Keefe, along with his colleagues Moser and Moser, is well-deserved recognition for truly ground-breaking science – science which, in time, could have profound ramifications for the way we understand and treat neurological diseases like Alzheimer’s.

Market success for university research

The recent success of Imperial College in realising £10m cash in exchange for a 10 per cent share holding in Imperial Innovations shows the continued market interest in the commercialisation of university research (report, 24 June).

Letters to the Editor - 17/03 - Science startups, Best of Twitter

[Re: Why Britain’s scientists are failing at business, Friday]
Tim Farron is right to highlight some of the challenges facing all entrepreneurs in this country, but the idea that Britain’s scientific community is failing at business is simply not accurate. More...